table of content
1 Introduction to Research & Analysis Reports
1.1 HIV Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Drug Type
1.2.2 Market by Application
1.3 Global HIV Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global HIV Therapy Overall Market Size
2.1 Global HIV Therapy Market Size: 2021 VS 2028
2.2 Global HIV Therapy Revenue, Prospects & Forecasts: 2017-2028
2.3 Global HIV Therapy Sales: 2017-2028
3 Company Landscape
3.1 Top HIV Therapy Players in Global Market
3.2 Top Global HIV Therapy Companies Ranked by Revenue
3.3 Global HIV Therapy Revenue by Companies
3.4 Global HIV Therapy Sales by Companies
3.5 Global HIV Therapy Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 HIV Therapy Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers HIV Therapy Product Type
3.8 Tier 1, Tier 2 and Tier 3 HIV Therapy Players in Global Market
3.8.1 List of Global Tier 1 HIV Therapy Companies
3.8.2 List of Global Tier 2 and Tier 3 HIV Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Drug Type - Global HIV Therapy Market Size Markets, 2021 & 2028
4.1.2 Integrase Inhibitors
4.1.3 Non- Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
4.1.4 Combination HIV Medicines
4.1.5 Others
4.2 By Drug Type - Global HIV Therapy Revenue & Forecasts
4.2.1 By Drug Type - Global HIV Therapy Revenue, 2017-2022
4.2.2 By Drug Type - Global HIV Therapy Revenue, 2023-2028
4.2.3 By Drug Type - Global HIV Therapy Revenue Market Share, 2017-2028
4.3 By Drug Type - Global HIV Therapy Sales & Forecasts
4.3.1 By Drug Type - Global HIV Therapy Sales, 2017-2022
4.3.2 By Drug Type - Global HIV Therapy Sales, 2023-2028
4.3.3 By Drug Type - Global HIV Therapy Sales Market Share, 2017-2028
4.4 By Drug Type - Global HIV Therapy Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global HIV Therapy Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.1.5 Others
5.2 By Application - Global HIV Therapy Revenue & Forecasts
5.2.1 By Application - Global HIV Therapy Revenue, 2017-2022
5.2.2 By Application - Global HIV Therapy Revenue, 2023-2028
5.2.3 By Application - Global HIV Therapy Revenue Market Share, 2017-2028
5.3 By Application - Global HIV Therapy Sales & Forecasts
5.3.1 By Application - Global HIV Therapy Sales, 2017-2022
5.3.2 By Application - Global HIV Therapy Sales, 2023-2028
5.3.3 By Application - Global HIV Therapy Sales Market Share, 2017-2028
5.4 By Application - Global HIV Therapy Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global HIV Therapy Market Size, 2021 & 2028
6.2 By Region - Global HIV Therapy Revenue & Forecasts
6.2.1 By Region - Global HIV Therapy Revenue, 2017-2022
6.2.2 By Region - Global HIV Therapy Revenue, 2023-2028
6.2.3 By Region - Global HIV Therapy Revenue Market Share, 2017-2028
6.3 By Region - Global HIV Therapy Sales & Forecasts
6.3.1 By Region - Global HIV Therapy Sales, 2017-2022
6.3.2 By Region - Global HIV Therapy Sales, 2023-2028
6.3.3 By Region - Global HIV Therapy Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America HIV Therapy Revenue, 2017-2028
6.4.2 By Country - North America HIV Therapy Sales, 2017-2028
6.4.3 US HIV Therapy Market Size, 2017-2028
6.4.4 Canada HIV Therapy Market Size, 2017-2028
6.4.5 Mexico HIV Therapy Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe HIV Therapy Revenue, 2017-2028
6.5.2 By Country - Europe HIV Therapy Sales, 2017-2028
6.5.3 Germany HIV Therapy Market Size, 2017-2028
6.5.4 France HIV Therapy Market Size, 2017-2028
6.5.5 U.K. HIV Therapy Market Size, 2017-2028
6.5.6 Italy HIV Therapy Market Size, 2017-2028
6.5.7 Russia HIV Therapy Market Size, 2017-2028
6.5.8 Nordic Countries HIV Therapy Market Size, 2017-2028
6.5.9 Benelux HIV Therapy Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia HIV Therapy Revenue, 2017-2028
6.6.2 By Region - Asia HIV Therapy Sales, 2017-2028
6.6.3 China HIV Therapy Market Size, 2017-2028
6.6.4 Japan HIV Therapy Market Size, 2017-2028
6.6.5 South Korea HIV Therapy Market Size, 2017-2028
6.6.6 Southeast Asia HIV Therapy Market Size, 2017-2028
6.6.7 India HIV Therapy Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America HIV Therapy Revenue, 2017-2028
6.7.2 By Country - South America HIV Therapy Sales, 2017-2028
6.7.3 Brazil HIV Therapy Market Size, 2017-2028
6.7.4 Argentina HIV Therapy Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa HIV Therapy Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa HIV Therapy Sales, 2017-2028
6.8.3 Turkey HIV Therapy Market Size, 2017-2028
6.8.4 Israel HIV Therapy Market Size, 2017-2028
6.8.5 Saudi Arabia HIV Therapy Market Size, 2017-2028
6.8.6 UAE HIV Therapy Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 ViiV Healthcare
7.1.1 ViiV Healthcare Corporate Summary
7.1.2 ViiV Healthcare Business Overview
7.1.3 ViiV Healthcare HIV Therapy Major Product Offerings
7.1.4 ViiV Healthcare HIV Therapy Sales and Revenue in Global (2017-2022)
7.1.5 ViiV Healthcare Key News
7.2 Gilead Sciences, Inc.
7.2.1 Gilead Sciences, Inc. Corporate Summary
7.2.2 Gilead Sciences, Inc. Business Overview
7.2.3 Gilead Sciences, Inc. HIV Therapy Major Product Offerings
7.2.4 Gilead Sciences, Inc. HIV Therapy Sales and Revenue in Global (2017-2022)
7.2.5 Gilead Sciences, Inc. Key News
7.3 GlaxoSmithKline Plc
7.3.1 GlaxoSmithKline Plc Corporate Summary
7.3.2 GlaxoSmithKline Plc Business Overview
7.3.3 GlaxoSmithKline Plc HIV Therapy Major Product Offerings
7.3.4 GlaxoSmithKline Plc HIV Therapy Sales and Revenue in Global (2017-2022)
7.3.5 GlaxoSmithKline Plc Key News
7.4 Merck Sharp & Dohme Corp.
7.4.1 Merck Sharp & Dohme Corp. Corporate Summary
7.4.2 Merck Sharp & Dohme Corp. Business Overview
7.4.3 Merck Sharp & Dohme Corp. HIV Therapy Major Product Offerings
7.4.4 Merck Sharp & Dohme Corp. HIV Therapy Sales and Revenue in Global (2017-2022)
7.4.5 Merck Sharp & Dohme Corp. Key News
7.5 Bristol-Myers Squibb Company
7.5.1 Bristol-Myers Squibb Company Corporate Summary
7.5.2 Bristol-Myers Squibb Company Business Overview
7.5.3 Bristol-Myers Squibb Company HIV Therapy Major Product Offerings
7.5.4 Bristol-Myers Squibb Company HIV Therapy Sales and Revenue in Global (2017-2022)
7.5.5 Bristol-Myers Squibb Company Key News
7.6 Janssen Pharmaceuticals, Inc.
7.6.1 Janssen Pharmaceuticals, Inc. Corporate Summary
7.6.2 Janssen Pharmaceuticals, Inc. Business Overview
7.6.3 Janssen Pharmaceuticals, Inc. HIV Therapy Major Product Offerings
7.6.4 Janssen Pharmaceuticals, Inc. HIV Therapy Sales and Revenue in Global (2017-2022)
7.6.5 Janssen Pharmaceuticals, Inc. Key News
7.7 Boehringer Ingelheim International GmbH
7.7.1 Boehringer Ingelheim International GmbH Corporate Summary
7.7.2 Boehringer Ingelheim International GmbH Business Overview
7.7.3 Boehringer Ingelheim International GmbH HIV Therapy Major Product Offerings
7.7.4 Boehringer Ingelheim International GmbH HIV Therapy Sales and Revenue in Global (2017-2022)
7.7.5 Boehringer Ingelheim International GmbH Key News
7.8 AbbVie Inc.
7.8.1 AbbVie Inc. Corporate Summary
7.8.2 AbbVie Inc. Business Overview
7.8.3 AbbVie Inc. HIV Therapy Major Product Offerings
7.8.4 AbbVie Inc. HIV Therapy Sales and Revenue in Global (2017-2022)
7.8.5 AbbVie Inc. Key News
7.9 Genentech, Inc.
7.9.1 Genentech, Inc. Corporate Summary
7.9.2 Genentech, Inc. Business Overview
7.9.3 Genentech, Inc. HIV Therapy Major Product Offerings
7.9.4 Genentech, Inc. HIV Therapy Sales and Revenue in Global (2017-2022)
7.9.5 Genentech, Inc. Key News
7.10 Mylan N.V.
7.10.1 Mylan N.V. Corporate Summary
7.10.2 Mylan N.V. Business Overview
7.10.3 Mylan N.V. HIV Therapy Major Product Offerings
7.10.4 Mylan N.V. HIV Therapy Sales and Revenue in Global (2017-2022)
7.10.5 Mylan N.V. Key News
8 Global HIV Therapy Production Capacity, Analysis
8.1 Global HIV Therapy Production Capacity, 2017-2028
8.2 HIV Therapy Production Capacity of Key Manufacturers in Global Market
8.3 Global HIV Therapy Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HIV Therapy Supply Chain Analysis
10.1 HIV Therapy Industry Value Chain
10.2 HIV Therapy Upstream Market
10.3 HIV Therapy Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 HIV Therapy Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
